Interstitial IgG antibody pharmacokinetics assessed by combinedin vivo- and physiologically-based pharmacokinetic modelling approaches-Reference-Cited by-同舟云学术

Interstitial IgG antibody pharmacokinetics assessed by combinedin vivo- and physiologically-based pharmacokinetic modelling approaches

Published:2017-10-29 Issue:24 Volume:595 Page:7311-7330
ISSN:0022-3751
Container-title:The Journal of Physiology
language:en
Short-container-title:J Physiol

Author:

Eigenmann Miro J.¹²^ORCID,Karlsen Tine V.²,Krippendorff Ben-Fillippo¹,Tenstad Olav²,Fronton Ludivine¹,Otteneder Michael B.¹,Wiig Helge²

Affiliation:

1. Roche Pharma Research and Early Development; Pharmaceutical Sciences; Roche Innovation Centre Basel; Switzerland

2. Department of Biomedicine; University of Bergen; Norway

Funder

Norges Forskningsråd

Publisher

Wiley

Subject

Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1113/JP274819/fullpdf

Reference40 articles.

1. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume;Aukland;Physiol Rev,1993

2. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice;Baxter;Cancer Res,1994

3. Compartmental tissue distribution of antibody therapeutics: experimental approaches and interpretations;Boswell;AAPS J,2012

4. Comparative physiology of mice and rats: radiometric measurement of vascular parameters in rodent tissues;Boswell;Mol Pharm,2014

5. Physiological parameter values for physiologically based pharmacokinetic models;Brown;Toxicol Ind Health,1997

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system;Molecular Therapy - Nucleic Acids;2024-06

2. A minimal physiologically based pharmacokinetic model to study the combined effect of antibody size, charge, and binding affinity to FcRn/antigen on antibody pharmacokinetics;Journal of Pharmacokinetics and Pharmacodynamics;2024-02-24

3. Physiologically based pharmacokinetic (PBPK) model that describes enhanced FcRn-dependent distribution of monoclonal antibodies (mAbs) by pI-engineering in mice;Drug Metabolism and Pharmacokinetics;2023-12

4. Dosing Strategy of Immunoglobulin (IgG) Replacement Therapies in Obese and Overweight Patients with Primary Immunodeficiency Diseases (PIDDs): A Meta‐Analysis of Clinical Trials;The Journal of Clinical Pharmacology;2023-11

5. Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation;Biochimica et Biophysica Acta (BBA) - General Subjects;2023-11